New Gene Linked to Greater Risk of
Brain & Ovarian Cancers
The two studies scanned the genomes of tens of thousand of individuals with and without these forms of cancer and revealed 13 new gene mutations linked to increased risk of glioma — the most common form of brain cancer — and 12 new gene variants that increase the risk of developing ovarian cancer.
One of the genetic changes discovered increases risk of brain cancer by as much as a third, with the rest by at least 15%.
Prior to the new study, 23 gene variants were already known to be linked to an increased risk of ovarian cancer, said Kuchenbaecker. This study identified an additional 12. The findings might also one day help people with a family history become better informed about their risk of developing a brain tumor so they can be aware of any signs of the disease.
“We urgently need to find new ways to tackle hard-to-treat cancers like brain tumors. Finding new genetic changes linked to brain tumors could give us important new clues about how and why these cancers develop,” said Dr. Catherine Pickworth, Cancer Research UK’s science information officer.
“The next steps will [be] finding out if any of these clues help to develop effective treatments for people with brain tumors.”
BREAST AND OVARIAN CANCER
Join us for the seventh annual Cheryl Diamond NYC 5K SCHLEP: Breast & Ovarian Cancer Run / Walk on Sunday, June 4th, 2017 at Battery Park, NYC.
The NYC 5K SCHLEP raises global awareness for BRCA genetic screening for breast & ovarian cancer, supports global research studies on breast and ovarian cancer cures, and BRCA mutation carriers, and benefits the BRCA Multidisciplinary Clinic at Israel’s Rabin Medical Center, the premier hospital in the Middle East.
To register your team, please visit http://www.afrmc.kintera.org/SCHLEP17 or call the American Friends of Rabin Medical Center office at 212-279-2522 or email firstname.lastname@example.org.